Clinical Trial Update: Acquired Immunodeficiency in ANCA Associated Vasculitis [Phase 2]

View source ↗

Summary

This clinical trial update notes a Phase 2 study on acquired immunodeficiency in ANCA-associated vasculitis; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Systemic Vasculitis | Phase 2 | Status: UNKNOWN